SCHEMBL3451624

SCHEMBL3451624

CC(C)c1ccc(-c2csc(N(Cc3cccs3)Cc3ccccc3C#N)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 3/20 0.35
PGR P06401 2/20 0.35
CYP2C19 P33261 1/20 0.35
HPGD P15428 1/20 0.35
MAPT P10636 3/20 0.35
TP53 P04637 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
POLB P06746 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MRE11 P49959 1/20 0.34
LMNA P02545 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TRPM8 Q7Z2W7 1/20 0.33
MAPK1 P28482 1/20 0.33
TRPA1 O75762 1/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3453550 0.82 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDMAPTTP53
SCHEMBL3452792 0.82 MEN1 (0.42) ALDH1A1KDM4ECYP2C19HPGDMAPT
SCHEMBL3451935 0.81 MEN1 (0.41) ALDH1A1KDM4ECYP2C19HPGDMAPT
SCHEMBL3451929 0.81 MEN1 (0.40) ALDH1A1KDM4EHPGDMAPTTP53
SCHEMBL3453293 0.79 ALDH1A1 (0.33) ALDH1A1KDM4EHPGDMAPTMEN1
SCHEMBL3451667 0.77 MEN1 (0.41) ALDH1A1KDM4ECYP2C19HPGDMAPT
SCHEMBL13109743 0.77 KDM4E (0.43) ALDH1A1KDM4EHPGDMAPTTP53
Hydrochloric Acid SCHEMBL3452295 0.77 KDM4E (0.43) ALDH1A1KDM4EHPGDMAPTTP53
SCHEMBL3452179 0.76 GCGR (0.44) ALDH1A1KDM4EHPGDMAPTMEN1
SCHEMBL13109591 0.76 GRM1 (0.40) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820704-B2 Substituted heteroaryl derivatives, compositions, and methods of use TRANSTECH PHARMA, INC. (US) 2010-10-26 US disclosed
EP-1753735-A1 SUBSTITUTED THIAZOLE AND PYRIMIDINE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS Transtech Pharma, Inc. (US) 2007-02-21 EP disclosed
US-20050261294-A1 Substituted heteroaryl derivatives, compositions, and methods of use VTVX HOLDINGS I LLC 2005-11-24 US disclosed
WO-2005103022-A1 SUBSTITUTED THIAZOLE AND PYRIMIDINE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS TRANSTECH PHARMA, INC. (US) 2005-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261294-A1 Substituted heteroaryl derivatives, compositions, and methods of use MC5R, MC3R, MC4R ALDH1A1 1513/4885KDM4E 2378/4885PGR 325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.